Association between the use of selective serotonin reuptake inhibitors and multiple sclerosis disability progression

Publisher： John Wiley & Sons Inc

E-ISSN： 1099-1557|25|10|1150-1159

ISSN： 1053-8569

Source： PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, Vol.25, Iss.10, 2016-10, pp. : 1150-1159

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The economic implications of the racial and ethnic disparities in the use of selective serotonin reuptake inhibitors

By Wang Junling   White-Means Shelley I.   Hufstader Meghan A.   Walker Genene D.  

Current Medical Research and Opinion, Vol. 23, Iss. 4, 2007-04 ,pp. : 853-863

Informa Healthcare

Access to resources Recommend Favorite

Should the Use of Selective Serotonin Reuptake Inhibitors in Child and Adolescent Depression Be Banned?

By  

Psychotherapy and Psychosomatics, Vol. 76, Iss. 1, 2006-12 ,pp. : 5-14

Karger

Access to resources Recommend Favorite

The use of selective serotonin reuptake inhibitors in geriatric depression: a review of the literature

By  

Reviews in Clinical Gerontology, Vol. 5, Iss. 4, 1995-11 ,pp. : 442-455

Cambridge University Press

Access to resources Recommend Favorite

Association Between Change in Physical Activity and Short-Term Disability Progression in Multiple Sclerosis

By Motl Robert W.   McAuley Edward  

Journal of Rehabilitation Medicine, Vol. 43, Iss. 4, 2011-03 ,pp. : 305-310

Medical Journals Limited

Access to resources Recommend Favorite

Preadmission use of selective serotonin reuptake inhibitors and short‐term mortality in diabetic patients hospitalized due to stroke

By  

JOURNAL OF INTERNAL MEDICINE, Vol. 280, Iss. 4, 2016-10 ,pp. : 407-418

John Wiley & Sons Inc

Access to resources Recommend Favorite